SYN-PAH-001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSYN-PAH-001
Drug Alias NameDNA-based therapy (Synthetic Biologics)SYN-PAH-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases stimulants
TargetsCyclooxygenases
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheriva Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheriva Biologics Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A